Convergence Investment Partners LLC Grows Stock Holdings in Cigna Group $CI

Convergence Investment Partners LLC increased its stake in shares of Cigna Group (NYSE:CI) by 37.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,098 shares of the health services provider’s stock after purchasing an additional 1,923 shares during the period. Convergence Investment Partners LLC’s holdings in Cigna Group were worth $1,953,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in CI. Beacon Financial Strategies CORP purchased a new position in shares of Cigna Group during the fourth quarter valued at approximately $28,000. Lodestone Wealth Management LLC purchased a new position in shares of Cigna Group during the fourth quarter valued at approximately $32,000. Collier Financial purchased a new position in shares of Cigna Group during the third quarter valued at approximately $34,000. Activest Wealth Management raised its holdings in shares of Cigna Group by 1,050.0% during the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 126 shares during the last quarter. Finally, True Wealth Design LLC raised its holdings in shares of Cigna Group by 116.4% during the fourth quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock valued at $43,000 after purchasing an additional 85 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Mizuho set a $330.00 price objective on shares of Cigna Group in a report on Friday, May 1st. Sanford C. Bernstein upped their target price on shares of Cigna Group from $358.00 to $371.00 and gave the company an “outperform” rating in a report on Tuesday, May 5th. Wells Fargo & Company upped their target price on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a report on Friday, May 1st. TD Cowen upped their target price on shares of Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a report on Monday, February 9th. Finally, Robert W. Baird set a $337.00 target price on shares of Cigna Group in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and an average target price of $338.35.

Insiders Place Their Bets

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 205,904 shares of company stock worth $60,277,068 over the last three months. 0.60% of the stock is currently owned by company insiders.

Cigna Group Stock Down 3.3%

Shares of CI stock opened at $285.25 on Friday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89. The stock has a market cap of $75.46 billion, a P/E ratio of 12.09, a P/E/G ratio of 1.03 and a beta of 0.30. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a 50 day simple moving average of $274.95 and a two-hundred day simple moving average of $275.97.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the company earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts expect that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is presently 26.45%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.